Suraksha Diagnostic Ltd is a trusted name in the healthcare industry, offering a wide range of diagnostic and healthcare services. The company is known for its state-of-the-art laboratories, advanced imaging technologies, and a customer-first approach. Suraksha Diagnostic provides services such as blood tests, pathology, radiology, and health check-ups, catering to individuals and healthcare providers alike. Suraksha Diagnostic Share Price on NSE as of 12 December 2024 is 410.00 INR. Here are more details on Suraksha Diagnostic Share Price Target 2024, 2025, 2026 to 2030.
Suraksha Diagnostic Ltd: Market Overview
- Open Price: ₹417.00
- High Price: ₹418.35
- Low Price: ₹406.00
- Previous Close: ₹417.75
- Volume: 625,887
- Value (Lacs): ₹2,569.58
- VWAP: ₹410.42
- UC Limit: ₹501.30
- LC Limit: ₹334.20
- 52 Week High: ₹441.00
- 52 Week Low: ₹402.10
- Mkt Cap: ₹2,138Cr
- Face Value: ₹2
Suraksha Diagnostic Share Price Chart
Suraksha Diagnostic Share Price Target Tomorrow 2024 To 2030
Suraksha Diagnostic Share Price Target Years | Share Price Target |
2024 | ₹450 |
2025 | ₹550 |
2026 | ₹650 |
2027 | ₹750 |
2028 | ₹850 |
2029 | ₹950 |
2030 | ₹1050 |
Suraksha Diagnostic Share Price Target 2024
Suraksha Diagnostic share price target 2024 Expected target could be ₹450. Here are four key factors that could influence the growth of Suraksha Diagnostic Ltd’s share price target for 2024:
- Rising Demand for Healthcare Services: Increasing health awareness and the need for preventive healthcare are likely to drive higher demand for diagnostic services, boosting Suraksha Diagnostic’s revenue.
- Geographic Expansion: Expanding its presence in untapped regions or opening more diagnostic centers can enhance the company’s market share and profitability.
- Technological Upgrades: Investing in advanced diagnostic tools and technologies can improve service quality and attract more customers, strengthening the company’s competitive edge.
-
Collaborations with Healthcare Providers: Partnerships with hospitals, clinics, and insurance companies can create steady revenue streams and contribute to the company’s growth in 2024.
Suraksha Diagnostic Share Price Target 2025
Suraksha Diagnostic share price target 2025 Expected target could be ₹550. Here are four key risks and challenges that could impact Suraksha Diagnostic Ltd’s share price target for 2025:
- Intense Market Competition: The diagnostic industry is highly competitive, with many players offering similar services. Suraksha Diagnostic may face pressure on pricing and market share, which could impact profitability.
- Regulatory and Compliance Challenges: Changes in healthcare regulations or stricter compliance requirements could increase operational costs or create barriers to expansion, impacting growth prospects.
- Fluctuations in Demand: The demand for diagnostic services may be affected by seasonal trends, economic conditions, or changes in consumer healthcare spending, leading to potential revenue volatility.
-
Technological Costs: While adopting new technologies is essential for growth, the costs associated with upgrading equipment or implementing advanced systems may impact profitability, particularly if the investments don’t yield quick returns.
Suraksha Diagnostic Share Price Target 2030
Suraksha Diagnostic share price target 2030 Expected target could be ₹1050. Here are four key risks and challenges that could impact Suraksha Diagnostic Ltd’s share price target for 2030:
- Technological Disruption: Rapid advancements in diagnostic technology, such as AI-driven tools or home-based diagnostic solutions, could challenge Suraksha Diagnostic’s traditional business model and require heavy investment to stay competitive.
- Economic Uncertainty: Economic downturns or changes in healthcare funding could lead to reduced consumer spending on diagnostic services, affecting revenue and growth potential.
- Regulatory Changes: Stricter healthcare regulations or changes in reimbursement policies from insurance providers could increase operational costs or limit profit margins, affecting the company’s long-term growth.
-
Healthcare Industry Consolidation: As the healthcare and diagnostics sectors consolidate, larger players may dominate the market, making it difficult for smaller companies like Suraksha Diagnostic to maintain their market share or grow at the same rate.
Shareholding Pattern For Suraksha Diagnostic Ltd
- Promoters: 48.78%
- FII: 15.64%
- DII: 16.68%
- Public: 18.89%
Suraksha Diagnostic Ltd Financials
(INR) | 2024 | Y/Y change |
Revenue | 2.19B | 15.03% |
Operating expense | 1.44B | 3.88% |
Net income | 236.26M | 262.58% |
Net profit margin | 10.80 | 214.87% |
Earnings per share | — | — |
EBITDA | 555.14M | 85.42% |
Effective tax rate | 26.40% | — |
Read Also:- Stock Market Update – BBAI Stock Price Prediction Tomorrow 2024 To 2030